Industry Reports
King Pharmaceuticals, Inc announced total revenue for the second quarter ended June 30, 2010
King Pharmaceuticals, Inc.announced that total revenue for the second quarter ended June 30, 2010 equaled $371 million compared to $445 million in the second quarter of 2009. The Company reported net income of $18.0 million and diluted earnings per...
Industry Reports
Amylin Pharmaceuticals Reports Second Quarter Results total revenue of $164.4 for the quarter ended June 30, 2010
Amylin Pharmaceuticals, Inc. reported financial results for the quarter ended June 30, 2010. The Company reported total revenue of $164.4 million for the quarter ended June 30, 2010, which includes net product sales of $162.5 million. Net loss, excluding...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.